Layoffs
NewLink Genetics has announced, with the company restructuring and layoffs, they are refocusing on indoximod.
Achaogen, headquartered in South San Francisco, announced that as part of its strategic update and corporate restructuring, it will eliminate 80 positions, or about 28 percent of staff.
The Novartis Institutes for BioMedical Research (NIBR) is ending its early-stage anti-infectives research programs located in Emeryville, California. As a result, the company expects to lay off about 140 employees.
Changes continue coming to Vivek Ramaswamy’s Roivant Sciences following a June shakeup that saw a 10 percent cut in employment and the restructuring of its business operations.
Shares of Regulus Therapeutics saw something of a slight rally on Monday following a post-Independence Day corporate restructuring announcement that included the termination of 60 percent of its workforce, which caused a massive stock plummet.
Roivant Sciences, Vivek Ramaswamy’s umbrella company for his family of “Vants,” announced major restructuring that includes a cut of 10 percent of staff and reshuffling of leadership.
Purdue Pharma, best known for selling painkiller OxyContin, announced it laid off approximately 350 staffers.
IBM recently reported a round of layoffs at its Watson Health unit, which uses artificial intelligence (AI) to work in healthcare.
Flex Pharma announced in a Corporate Update that it is closing an ongoing Phase II clinical trial of FLX-787 in ALS and CMT while shifting its strategy to focus on other approaches.
Danish company Novo Nordisk is reportedly considering cost-cutting plans that would cut up to 3,000 jobs.
PRESS RELEASES
